Larynx Cancer: Clinical Trials

44 trials for Larynx Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 7 recruiting, 4 unknown, 3 terminated. 11 Not applicable, 11 Phase 2, 5 Phase 1, 5 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 6, Recruiting 3, Unknown 1, Withdrawn 1
Phase 211Completed 5, Active not recruiting 2, Recruiting 2, Not yet recruiting 1, Unknown 1
Phase 15Completed 3, Terminated 1, Withdrawn 1
Phase 35Completed 4, Recruiting 1
Early Phase 11Terminated 1

Follow Larynx Cancer: new trials by email Literature Review of Larynx Cancer trials Research Report on Larynx Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
Capecitabine, Standard of Care (SOC) - Head Neck Cancer, Mouth Cancer
Phase 2Not yet recruitingSir Mortimer B. Davis - Jewish General Hospital752026-01-012025-11-28
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Sacituzumab Govitecan, Cetuximab - Squamous Cell Carcinoma of Head and Neck, Sinus Cancer
Phase 2RecruitingMemorial Sloan Kettering Cancer Center402025-07-022026-02-19
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Vesanoid, Standard radiotherapy, Tailored radiotherapy - Oropharynx Cancer, Larynx Cancer
Phase 3RecruitingCentre Leon Berard4602025-02-202026-04-24
Evaluations of Alcohol Warning Labels
Narrative pictorial warning labels for alcoholic beverages, Non-narrative pictorial warning labels for alcoholic beverages - Oral Cancer, Esophageal Cancer
Not applicableCompletedUniversity of Connecticut10532024-01-192025-11-14
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers
Zimberelimab, Etrumadenant, Cisplatin - Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck
Phase 1WithdrawnJennifer Choe2023-12-312023-11-30
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
ENDURE - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Not applicableRecruitingMedical University of South Carolina5322023-10-302025-12-11
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
Surgery, Radiation, Toripalimab - Larynx Cancer, Hypopharyngeal Cancer
Phase 2RecruitingFudan University822023-08-222023-09-15
GI Organ Tracking Via Balloon Applicators
Balloon-tipped catheter - Esophageal Cancer, Kidney Cancer
Not applicableWithdrawnWashington University School of Medicine2023-04-252024-06-13
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors
ENHANCE Intervention - Exercise and Nutrition, ENHANCE Intervention - Nutrition Only - Oral Cavity Cancer, Oropharynx Cancer
Not applicableCompletedH. Lee Moffitt Cancer Center and Research Institute402023-04-062026-09-17
Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
High-speed video endoscopy (HSV), Acoustic voice analysis, Quality of life questionnaire - Larynx Cancer, Laryngectomy; Status
CompletedOsijek University Hospital552022-08-012026-03-31
Immunological Function After Radiation With Either Proton or Photon Therapy
blood draws - HNSCC, Head and Neck Cancer
UnknownUniversity Medical Center Groningen402021-09-232023-08-30
Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy
Pharyngeal Cancer, Swallowing Disorder
CompletedCentre Hospitalier de Valence2252021-07-032025-09-08
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
HNSCC, Oral Cavity Cancer
RecruitingUniversity Hospital Freiburg15002021-06-012025-03-25
The Registry of Oncology Outcomes Associated With Testing and Treatment
Biomarker Testing (L), Systemic Treatment (T), Patient Reported Outcomes (P) - Adenocarcinoma, Adenocystic Carcinoma
CompletedTaproot Health1672021-05-052024-12-18
Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers
to assess the voice perception of the patient undergoing phonatory prosthesis placement surgery by evaluating the optimal score (>30) in terms of VHI. - Quality of Life, Larynx Cancer
UnknownRegina Elena Cancer Institute312021-05-042023-10-17
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Viewray MRIdian® Linac - Gastric Cancer, Invasive Breast Cancer
Not applicableRecruitingBrigham and Women's Hospital702021-05-012026-02-09
Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
Elective bilateral neck dissection in cN0 patients - Neck Cancer, Larynx
CompletedFondazione Policlinico Universitario Agostino Gemelli IRCCS802020-09-012023-02-28
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
Single Vocal Cord Irradiation (SVCI), Arm A: Transoral CO2-Laser Microsurgical Cordectomy (TLM) - Glottis Tumor, Larynx Cancer
Not applicableRecruitingOlgun Elicin342019-11-202025-10-07
Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
Vocal-cord Radiotherapy, Complete Larynx Radiotherapy - Cancer Neck, Larynx Cancer
Phase 2Active not recruitingCentre hospitalier de l'Université de Montréal (CHUM)1552018-10-112025-03-21
Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy
Tritube, Standard enditracheal tube - Oral Neoplasm, Pharynx Cancer
Not applicableCompletedMichael Seltz Kristensen482018-09-122024-02-29

Showing 20 of 44. Sign in to see all of them.

Narrower conditions

Laryngeal Neoplasms (44)  ·  Mouth Neoplasms (18)  ·  Head and Neck Neoplasms (16)  ·  Hypopharyngeal Neoplasms (16)  ·  Oropharyngeal Neoplasms (16)  ·  Squamous Cell Carcinoma of Head and Neck (11)  ·  Pharyngeal Neoplasms (7)  ·  Esophageal Neoplasms (5)  ·  Stomach Neoplasms (4)  ·  Carcinoma, Squamous Cell (3)  ·  Colonic Neoplasms (3)  ·  Laryngeal Diseases (3)  ·  Lip Neoplasms (3)  ·  Liver Neoplasms (3)  ·  Lung Neoplasms (3)

Broader conditions

Neoplasms by Site (44)  ·  Otorhinolaryngologic Diseases (44)  ·  Otorhinolaryngologic Neoplasms (44)  ·  Respiratory Tract Diseases (44)  ·  Respiratory Tract Neoplasms (44)  ·  Neoplasms (43)  ·  Laryngeal Diseases (41)  ·  Head and Neck Neoplasms (28)  ·  Stomatognathic Diseases (27)  ·  Pharyngeal Diseases (25)  ·  Mouth Diseases (19)  ·  Pharyngeal Neoplasms (18)  ·  Carcinoma (16)  ·  Neoplasms by Histologic Type (16)  ·  Neoplasms, Glandular and Epithelial (16)

Interventions

Cisplatin (8)  ·  Cetuximab (4)  ·  Fluorouracil (3)  ·  Radiation (3)  ·  Carboplatin (2)  ·  Docetaxel (2)  ·  Laryngoscopy (2)  ·  Surveys and Questionnaires (2)  ·  pembrolizumab (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  5-fluoro-3-pyridinecarboxylic acid (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Alcoholic Beverages (1)  ·  Biological Therapy (1)  ·  Blood Specimen Collection (1)

Sponsors

Groupe Oncologie Radiotherapie Tete et Cou (3)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  Gustave Roussy, Cancer Campus, Grand Paris (2)  ·  Atos Medical AB (1)  ·  Brigham and Women's Hospital (1)  ·  Centre Hospitalier de Valence (1)  ·  Centre Leon Berard (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Christian von Buchwald (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Fudan University (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Hacettepe University (1)  ·  Jennifer Choe (1)  ·  Klus Pharma Inc. (1)

Countries

United States (18)  ·  France (8)  ·  Netherlands (4)  ·  Denmark (2)  ·  Germany (2)  ·  Italy (2)  ·  Switzerland (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Cyprus (1)  ·  Czechia (1)  ·  India (1)

Top investigators

Aron Popovtzer, MD (1)  ·  Assuntina Sacco, M.D. (1)  ·  Brett Miles, MD (1)  ·  C. Jillian Tsai, MD (1)  ·  Christian Von Buchwald, MD, DMSc (1)  ·  David I Fielding, FRACP MD (1)  ·  David Palma (1)  ·  Dennis Kraus, MD (1)  ·  Edward J. Damrose MD, FACS (1)  ·  Evan M Graboyes, MD, MPH (1)  ·  Frank Hoebers, MD,PhD (1)  ·  Frans JM Hilgers, MD, PhD (1)

Results publications

PMID 21831465, PMID 23341517, PMID 29149611, PMID 30663068, PMID 32479189, PMID 33888069, PMID 33989559, PMID 36303192, PMID 40597116, PMID 40692081

NIH funding

2015 (1), R01CA282165 (1), R03CA273391 (1)